271 related articles for article (PubMed ID: 32458152)
1. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
Duan S; Luo X; Zeng H; Zhan X; Yuan C
Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop.
Wu G; Hao C; Qi X; Nie J; Zhou W; Huang J; He Q
Cell Death Dis; 2020 May; 11(5):393. PubMed ID: 32447342
[TBL] [Abstract][Full Text] [Related]
3. Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.
Hamester F; Stürken C; Saygi C; Qi M; Legler K; Gorzelanny C; Robador JR; Schmalfeldt B; Laakmann E; Müller V; Witzel I; Oliveira-Ferrer L
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163822
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane protein 92 performs a tumor-promoting function in breast carcinoma by contributing to the cell growth, invasion, migration and epithelial-mesenchymal transition.
Lin MZ; Teng LL; Sun XL; Zhang LP; Chen F; Yu LJ
Tissue Cell; 2020 Dec; 67():101415. PubMed ID: 32835947
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
6. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
8. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
Li Y; Wang YW; Chen X; Ma RR; Guo XY; Liu HT; Jiang SJ; Wei JM; Gao P
Clin Breast Cancer; 2020 Apr; 20(2):e113-e126. PubMed ID: 31899158
[TBL] [Abstract][Full Text] [Related]
11. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
12. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
[TBL] [Abstract][Full Text] [Related]
13. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
14. KIN17 promotes tumor metastasis by activating EMT signaling in luminal-A breast cancer.
Huang Q; Zahid KR; Chen J; Pang X; Zhong M; Huang H; Pan W; Yin J; Raza U; Zeng J; Zhu X; Zeng T
Thorac Cancer; 2021 Jul; 12(13):2013-2023. PubMed ID: 34008927
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.
Jin M; Gao D; Wang R; Sik A; Liu K
Oncol Rep; 2020 Aug; 44(2):555-564. PubMed ID: 32627030
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
19. Small nucleolar RNA SNORA71A promotes epithelial-mesenchymal transition by maintaining ROCK2 mRNA stability in breast cancer.
Hu T; Lu C; Xia Y; Wu L; Song J; Chen C; Wang Q
Mol Oncol; 2022 May; 16(9):1947-1965. PubMed ID: 35100495
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.
Lu G; Lai Y; Wang T; Lin W; Lu J; Ma Y; Chen Y; Ma H; Liu R; Li J
Aging (Albany NY); 2019 Nov; 11(22):10203-10219. PubMed ID: 31740625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
